Your browser doesn't support javascript.
loading
Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma.
Sengul Samanci, Nilay; Çelik, Emir; Bagcilar, Omer; Erol, Burak Caglar; Bicki, Ela; Oruc, Kerem; Bedir, Sahin; Degerli, Ezgi; Derin, Sumeyra; Demirci, Nebi Serkan; Demirelli, Fuat Hulusi.
  • Sengul Samanci N; Departments of Medical Oncology.
  • Çelik E; Departments of Medical Oncology.
  • Bagcilar O; Radiology.
  • Erol BC; Radiology.
  • Bicki E; Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Oruc K; Departments of Medical Oncology.
  • Bedir S; Departments of Medical Oncology.
  • Degerli E; Departments of Medical Oncology.
  • Derin S; Departments of Medical Oncology.
  • Demirci NS; Departments of Medical Oncology.
  • Demirelli FH; Departments of Medical Oncology.
Melanoma Res ; 30(5): 477-483, 2020 10.
Article en En | MEDLINE | ID: mdl-32898388

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oximas / Piperidinas / Piridonas / Pirimidinonas / Neoplasias Cutáneas / Azetidinas / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Vemurafenib / Imidazoles Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oximas / Piperidinas / Piridonas / Pirimidinonas / Neoplasias Cutáneas / Azetidinas / Proteínas Proto-Oncogénicas B-raf / Inhibidores de Proteínas Quinasas / Vemurafenib / Imidazoles Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article